XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities:    
Net Income (Loss) $ 87,894 $ (117,922)
Adjustments to reconcile net income (loss) to net cash flows used for operating activities:    
Depreciation 71,698 72,727
Amortization 18,997 19,058
Share-based compensation 37,888 30,280
Bad debt expense 5,475 877
Inventory obsolescence 18,672 21,263
Deferred income taxes 31,007 7,588
(Income) from equity method investments (12,200) (6,685)
Loss on extinguishment of long-term borrowings 0 83,213
(Gain) on sale of assets/business, net (15,177) (21,839)
Changes in assets and liabilities:    
Accounts receivable, net 68,797 239,567
Inventories (447,230) (338,313)
Prepaid expenses and other current assets (47,314) (14,700)
Accounts payable, accrued liabilities, and income taxes payable (226,218) (211,295)
Other, net (17,268) (5,189)
Net cash flows used for operating activities (424,979) (241,370)
Cash Flows From Investing Activities:    
Purchases of tools, dies, and molds (38,825) (34,355)
Purchases of other property, plant, and equipment (39,677) (40,317)
(Payments of) proceeds from foreign currency forward exchange contracts, net (460) 4,402
Proceeds from sale of assets/business 24,669 43,075
Other, net 749 0
Net cash flows used for investing activities (53,544) (27,195)
Cash Flows From Financing Activities:    
Proceeds from (payments of) short-term borrowings, net 3,446 (755)
Payments of long-term borrowings 0 (1,287,022)
Proceeds from long-term borrowings, net 0 1,185,117
Tax withholdings for share-based compensation (18,317) (7,495)
Proceeds from stock option exercises 26,282 3,264
Other, net (1,096) (884)
Net cash flows provided by (used for) financing activities 10,315 (107,775)
Effect of Currency Exchange Rate Changes on Cash and Equivalents 11,380 (1,098)
Decrease in Cash and Equivalents (456,828) (377,438)
Cash and Equivalents at Beginning of Period 731,362 762,181
Cash and Equivalents at End of Period $ 274,534 $ 384,743